Berkshire Hathaway reports higher Q1 operating earnings under new CEO Greg Abel

Berkshire Hathaway reported Q1 2026 operating earnings of $11.35 billion, up nearly 18% from $9.64 billion a year earlier, while also posting a record cash position. The results were the company’s first full quarter under new CEO Greg Abel and were driven by gains across core businesses, including insurance underwriting. The update is supportive for Berkshire fundamentals but is unlikely to move the broader market materially.

Analysis

The bigger signal is not the earnings beat itself but the optionality created by Berkshire’s balance sheet under a new capital allocator. A record cash buffer in an environment where many conglomerates are still forced into buybacks or levering up means BRK.B can be the buyer of last resort if dislocations emerge in insurance, rail, or industrials. That tends to compress volatility in Berkshire’s own equity while quietly raising the implied floor for stressed assets in its orbit, because counterparties know capital can appear fast and at scale.

Greg Abel’s first full-quarter optics matter because the market is now testing whether Berkshire behaves more like a passive compounding machine or an active capital recycler. If the new regime is even modestly more willing to deploy cash, the upside is not in headline EPS but in capital deployment timing: a few large deals or a meaningful repurchase window can re-rate the stock over months, not days. The converse is also true — if cash keeps building without deployment, the market may start discounting a governance transition premium fade and treat Berkshire more like a low-beta asset with limited catalyst density.

The underappreciated second-order effect is on competitors that rely on disciplined underwriting and patient capital. Stronger insurance earnings and abundant liquidity make Berkshire more dangerous in a soft market: it can underwrite through volatility longer than peers, potentially pressuring pricing in commercial lines and reinsurance over the next 2-4 quarters. That would be negative for public insurers with weaker reserves or more cyclical exposure, while reinforcing Berkshire’s ability to take share without needing aggressive risk-taking.

Consensus likely underestimates the gap between headline strength and near-term tradability. The stock probably won’t rerate solely on a good quarter; it needs evidence that capital is being put to work or that operational momentum is durable enough to justify a higher quality multiple. Without that, the setup is more about downside protection than explosive upside, but the cash cushion makes any pullback a cleaner entry point than usual.

Key Decisions for Investors

• Long BRK.B on 1-3 month horizon into any post-earnings drift lower; risk/reward favors owning the balance-sheet optionality with limited downside if the market waits for deployment catalysts.
• Sell downside volatility in BRK.B via 3-6 month put spreads if implied vol stays elevated; the cash fortress reduces left-tail risk unless a major acquisition or underwriting shock emerges.
• Pair trade: long BRK.B / short a basket of weaker commercial insurers or reinsurers over 2-4 quarters; Berkshire’s capital strength and underwriting discipline should pressure competitors if pricing softens.
• If BRK.B rallies sharply on headline enthusiasm, fade part of the move with a tight stop — the first-order earnings print is likely less important than future capital deployment, which may take months to materialize.
• Set a catalyst watch for large acquisitions or meaningful repurchases; if no deployment shows up over the next 1-2 quarters, reassess the multiple as governance-transition premium may not sustain.